Oxalys Innovation

Oxalys leaf 72dpi

Oxalys Pharmaceuticals is developing therapies to prevent, slow, or reverse the course of brain degeneration. Parkinson’s disease and Huntington’s disease are primary focus areas, and both have a strong unmet medical need.  The company’s drug discovery platform is designed to identify small molecules that suppress the toxic effects of mutations that have a causal role in neurodegeneration.  In this way, Oxalys is finding therapeutics that inhibit the underlying causes of diseases.



Leave a comment

May 12, 2014 · 11:19 pm

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s